Allahabad High Court Clarifies NDPS Act Rules for Codeine Syrup
On 1 September 2026, the Allahabad High Court clarified when the Narcotic Drugs and Psychotropic Substances (NDPS) Act applies to codeine-based cough syrup. Justice Arun Kumar Singh Deshwal delivered the ruling while disposing of a batch of bail applications.
Therapeutic Use and Diversion
The court held that the NDPS Act does not apply to codeine cough syrup lawfully used or traded for therapeutic purposes within prescribed limits, including the cited limit of 0.2%. Syrup diverted, stocked or sold for intoxication or trafficking may attract the Act, including where fake firms, bogus bills or missing valid documents are involved. For such diversion, the entire weight of the syrup mixture is considered when determining quantity, following Hira Singh v Union of India.
Direction to Drug Inspectors and Bail Decisions
The court directed the Food Safety and Drug Administration Commissioner of Uttar Pradesh to instruct drug inspectors to seek advice from the concerned government advocate before registering NDPS cases based on deficiencies at medical stores. It rejected bail applications by key accused, including Bhola Prasad, Vibhor Rana, Ankush Singh, Badal Arya and Harsh Agrawal. Bail was granted to many truck drivers, helpers and small retailers where their direct involvement in, or knowledge of, illicit diversion for intoxication could not be conclusively established.
Important Facts for Exams
- Territorial reach: The NDPS Act covers Indian citizens abroad and people aboard Indian-registered ships or aircraft, as well as conduct within India.
- Treaty obligations: The NDPS Act was designed to fulfil India’s obligations under three UN drug-control conventions, including the convention against illicit trafficking.